Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 9/20 | 0.42 |
| ▸ | ASPH | Q12797 | 2/20 | 0.42 |
| ▸ | KDM8 | Q8N371 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 5/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | AGER | Q15109 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | NAPRT | Q6XQN6 | 2/20 | 0.34 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | MYC | P01106 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30575282 | 1.00 | KDM4E (0.42) | KDM4EASPHKDM8MAPTALDH1A1 | |
| SCHEMBL13697273 | 0.81 | PDE3B (0.35) | ALDH1A1 | |
| SCHEMBL15145687 | 0.81 | ADORA3 (0.36) | ALDH1A1TSHRKMT2A | |
| SCHEMBL12548240 | 0.78 | KDM4E (0.41) | KDM4EASPHKDM8MAPTALDH1A1 | |
| SCHEMBL28285903 | 0.76 | YTHDC1 (0.33) | KDM4EMAPTALDH1A1NPSR1L3MBTL1 | |
| SCHEMBL69939 | 0.75 | KDM4E (0.54) | KDM4EASPHKDM8MAPTALDH1A1 | |
| Water SCHEMBL335807 | 0.73 | KDM4E (0.52) | KDM4EASPHKDM8MAPTALDH1A1 | |
| SCHEMBL6345905 | 0.73 | KDM4E (0.52) | KDM4EASPHKDM8MAPTALDH1A1 | |
| SCHEMBL29113117 | 0.73 | KDM4E (0.52) | KDM4EASPHKDM8MAPTALDH1A1 | |
| Hydrochloric Acid SCHEMBL9356765 | 0.73 | KDM4E (0.52) | KDM4EASPHKDM8MAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104245680-A | Process for producing 5- (difluoromethyl) pyrazine-2-carboxylic acid and production intermediate thereof | EISAI R&D MAN CO LTD | 2014-12-24 | — | — | CN | claimed |
| EP-2456763-A1 | OXAZINE DERIVATIVES AND THEIR USE AS BACE INHIBITORS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS | Novartis AG (CH) | 2012-05-30 | — | — | EP | claimed |
| CN-109641854-A | Integration stress access regulator | 卡里科生命科学有限责任公司 | 2019-04-16 | — | — | CN | disclosed |
| CN-104245680-A | Process for producing 5- (difluoromethyl) pyrazine-2-carboxylic acid and production intermediate thereof | EISAI R&D MAN CO LTD | 2014-12-24 | — | — | CN | disclosed |
| EP-2665716-A1 | METHODS AND COMPOUNDS USEFUL IN THE SYNTHESIS OF FUSED AMINODIHYDROTHIAZINE DERIVATIVES | Eisai R&D Management Co., Ltd. (JP) | 2013-11-27 | — | — | EP | disclosed |
| WO-2012100179-A1 | METHODS AND COMPOUNDS USEFUL IN THE SYNTHESIS OF FUSED AMINODIHYDROTHIAZINE DERIVATIVES | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2012-07-26 | — | — | WO | disclosed |
| EP-2456763-A1 | OXAZINE DERIVATIVES AND THEIR USE AS BACE INHIBITORS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS | Novartis AG (CH) | 2012-05-30 | — | — | EP | disclosed |
| US-8168638-B2 | Pyrazinecarboxamide derivatives and plant disease controlling agents containing the same | NIHON NOHYAKU CO., LTD. (JP) | 2012-05-01 | — | — | US | disclosed |
| EP-1963286-B1 | PYRAZINECARBOXAMIDE DERIVATIVES AND PLANT DISEASE CONTROLLING AGENTS CONTAINING THE SAME | NIHON NOHYAKU CO LTD (JP) | 2012-02-22 | — | — | EP | disclosed |
| CN-101341136-B | Pyrazinecarboxamide derivatives and plant disease controlling agents containing the same | NIHON NOHYAKU CO LTD | 2011-07-06 | — | — | CN | disclosed |
| US-20090233934-A1 | Pyrazinecarboxamide Derivatives and Plant Disease Controlling Agents Containing the Same | NIHON NOHYAKU CO., LTD. (JP) | 2009-09-17 | — | — | US | disclosed |
| CN-101341136-A | Pyrazinecarboxamide derivatives and plant disease controlling agents containing the same | NIHON NOHYAKU CO LTD (JP) | 2009-01-07 | — | — | CN | disclosed |
| EP-1963286-A1 | PYRAZINECARBOXAMIDE DERIVATIVES AND PLANT DISEASE CONTROLLING AGENTS CONTAINING THE SAME | Nihon Nohyaku Co., Ltd. (JP) | 2008-09-03 | — | — | EP | disclosed |
| WO-2007072999-A1 | PYRAZINECARBOXAMIDE DERIVATIVES AND PLANT DISEASE CONTROLLING AGENTS CONTAINING THE SAME | NIHON NOHYAKU CO., LTD (JP) | 2007-06-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090233934-A1 | Pyrazinecarboxamide Derivatives and Plant Disease Controlling Agents Containing the Same | CBR3, CNPY2, AADAC | KDM4E 3250/4885ASPH 2410/4885KDM8 3098/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.